b-rayZ, a Swiss innovator in AI-powered medical imaging solutions, proudly announces the receipt of the CE mark for the groundbreaking DANAI technology

January 22, 2024 — b-rayZ, a Swiss innovator in AI-powered medical imaging solutions, proudly announces the receipt of the CE mark for the groundbreaking DANAI technology. Seamlessly integrated into the comprehensive breast diagnostic suites, b-box plus, DANAI empowers breast cancer detection, density assessment and quality-controlled breast positioning. DANAI marks a significant milestone in radiology, introducing a pioneering Custom AI framework designed to dynamically adapt to the unique needs of breast imaging institutions and its professional staff. Representing a paradigm shift in AI technology, it leverages adaptability to seamlessly integrate within diverse clinical environments. This adaptable framework allows calibration to the distinct requirements of each imaging unit, thereby enhancing diagnostic accuracy and streamlining operational efficiencies. 

Prof. Dr. Cristina Rossi, CEO of b-rayZ, expressed her excitement over this accomplishment, stating, “The CE mark for DANAI is a tribute to our commitment to innovation and excellence in breast imaging. With this achievement, b-rayZ elevates itself in the medical industry as the first company to cover the entire mammography workflow, closing the last gap in the adoption of AI in each and every setting with Custom AI capabilities. This innovation revolutionizes the diagnostic landscape through our commitment to the highest quality breast cancer diagnostics.“ 

The DANAI technology is set to launch in the forthcoming weeks, coinciding with a grand showcase at the European Congress of Radiology (ECR) 2024 in Vienna. The event will offer an exclusive opportunity for industry professionals to experience firsthand the transformative capabilities and adaptability of DANAI within diverse clinical settings. 

b-rayZ is set to redefine AI capabilities with DANAI, offering a revolutionary custom AI framework that ensures optimal adaptability, safety, precision, and efficiency in diagnostic processes. The launch marks a pivotal moment in advancing the field of medical imaging, setting new standards for excellence and innovation. 

For more information: https://b-rayz.com


Related Content

News | Radiation Oncology

July 16, 2026 — Raidium has announced the U.S. launch of Raidium Read (R.Read), applying its AI-native imaging solution ...

Time July 16, 2026
arrow
Feature | Information Technology | Kyle Hardner

Artificial intelligence (AI) has enhanced diagnostic accuracy and improved triage in radiology. But far fewer tools ...

Time July 16, 2026
arrow
News | Ultrasound Imaging

July 7, 2026 — Longeviti Neuro Solutions has launched a new strategic initiative, ClearFit AI, a Brain Ultrasound ...

Time July 09, 2026
arrow
News | Prostate Cancer

July 8,2026 — CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, has announced the ...

Time July 08, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

July 7, 2026 — Imagion Biosystems, Ltd. recently announced it has renewed and extended its collaboration agreement with ...

Time July 07, 2026
arrow
News | Breast Imaging

July 7, 2026 — QT Imaging Holdings, Inc. recently announced it has successfully completed its first routine inspection ...

Time July 07, 2026
arrow
News | MRI Breast

July 2, 2026 – Quibim has announced the European and UK launch of QP-Breast, its CE and UKCA-marked AI tool which ...

Time July 02, 2026
arrow
News | Women's Health

July 1, 2026 — Despite declining birth rates worldwide, the complexity of pregnancy is increasing. Advanced maternal age ...

Time July 01, 2026
arrow
News | Mammography

June 30, 2026 — The Food and Drug Administration has cleared new contrast-enhanced mammography (CEM) and CEM biopsy ...

Time June 30, 2026
arrow
News | Information Technology

June 26, 2026 — Radin Health recently announced the successful deployment of its cloud-native platform at four ...

Time June 26, 2026
arrow
Subscribe Now